CBDual Biotechnology Corp Launches Revolutionary Teeth Polishing Paste with Cannabidiol (CBD)

NEWBURY PARK, Calif. - Nov. 11, 2019 - PRLog -- CBDual Biotechnology Corp.("the Company"), a subsidiary of THC Farmaceuticals, Inc (OTC PINK:CBDG)  a developer of CBD based oral healthcare products, is excited to announce today  the launch of a revolutionary Teeth Polishing Paste containing Cannabidiol (CBD). This is the first and only CBD dental polishing system of its kind that promotes both enamel and gum health through a customized dental care program.

Branded as "CB-Dual Prophy™", the new product includes a stain removing ingredients and polishing paste as well as a unique CBD oil formulation, customized to each specific patient's needs. This new compounded formulation, with dual benefit, allows dentists and hygienists to offer a potentially healthier and gentler approach to teeth polishing to preserve enamel and improve gums health.

"CB-Dual Prophy™ is a revolutionary new product that will change the whole dental industry's approach to teeth polishing," said Dr. Greg Rubin, CEO and Founder of the Company. "Teeth polishing in the dental industry has been known as having no therapeutic value, but by incorporating our CBD oil, we are looking to potentially improve overall gum health. Published clinical research indicates that CBD oil demonstrates both antibacterial and anti-inflammatory properties on gums."

Our team of dentists, scientists and product developers have done extensive research and testing to create the best and unique formula. CBDUAL Biotechnology has partnered with 1000SMILES DENTAL to engage in product testing on volunteers.

CB-Dual Prophy™ Teeth Polishing Paste will be manufactured gluten-free, sweetened with xylitol with a variety of flavors. In addition, fluoride can be added on demand for patients who need an extra layer of protection.

About CBDual Biotechnology Corp.

THC Farmaceuticals, Inc.: through its subsidiary, CBDual Biotechnology Corp., is a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The company's facility is located in Southern California where we provide easy access for patients to participate in clinical trials of new medical cannabis medications and psilocybin therapies, and products. CBDual Biotechnology Corp is a privately held, US Based Biotechnology company with propriety technology for enhanced oral delivery of bioactive cannabinoids. This technology promotes overall oral health due to higher effectiveness of the delivery methodology. The company was founded in 2016 and is headquartered in California, with its R&D in the US and Israel.

For additional information visit the company's website: https://cbdual.com and https://cbdg.com/

Follow us on Twitter @THCFarma (https://twitter.com/thcfarma?lang=en) and @CBDualBiotech (https://twitter.com/CBDualBiotech?lang=en)